|Day Low/High||165.16 / 167.21|
|52 Wk Low/High||114.27 / 197.00|
MAGNETIC MUSCLE STIMULATION TECHNOLOGY TO STRENGTHEN, TONE AND FIRM MUSCLES
The intermediate-term sentiment indicators don’t show too much giddiness -- yet -- but look at all the market has on its plate this week.
--BOTOX® is the First Neurotoxin Treatment Approved to Treat Pediatric Patients, 2 to 17 Years of Age, with Upper Limb Spasticity--
Aegon will repurchase 32,873,805 common shares to neutralize the dilutive effect of the 2018 final stock dividend.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE:AGN) today announced positive topline data from a Phase IIIb clinical trial evaluating LINZESS (linaclotide) 290 mcg on multiple abdominal symptoms in adult patients with IBS-C.
Today, Aegon Bank priced its inaugural EUR 500 million 5 year Senior Non-Preferred notes with a yield of 0.
Approval Based on Totality of Evidence Demonstrating KANJINTI is Biosimilar to Herceptin
A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.
Investors should consider recession-proof names in the current environment, Jim Cramer says.
South Korea is the plastic surgery capital of the world. These companies are manufacturing botox strains - but the big business is abroad, if they can crack the China and U.S. markets.
Aegon today announces that Sarah Russell (1962, Australian), member of Aegon's Management Board and Global CEO of Aegon Asset Management, will step down.
- New Indication Makes VRAYLAR First and Only Dopamine and Serotonin Partial Agonist to Treat the Full Spectrum of Bipolar I Symptoms in Manic, Mixed, and Depressive Episodes -
DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.
DUBLIN, May 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019 Healthcare Conference in New York, NY.
-- Five PLEDGE studies now active and enrolling patients to evaluate the safety and efficacy of relamorelin (investigational drug) in people with diabetic gastroparesis --
"With the evolving market conditions, we mutually agreed that the future of the variable annuity business in Japan is best served as a wholly-owned part of our longstanding partner Sony Life", said Alex Wynaendts, CEO of Aegon.
Jim Cramer says Thursday's market action showed us a rally based on good old-fashioned earnings.
These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.
DUBLIN, May 16, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.
Abstracts will showcase research on VRAYLAR, including a focus on an investigational use for the treatment of bipolar depression
PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is pleased to announce its partnership with Allergan plc on a year-long market research study...
Novartis gets a potentially blockbuster eye drug and Takeda gets to unload some debt and employees it took on when it purchased Shire.
DUBLIN, May 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, Nevada.
Stocks end down sharply as markets react to latest twists in trade spat between the U.S. and China.
Regeneron stock is under pressure after missing on earnings and revenue expectations. Are new lows on tap?
Allergan posted stronger-than-expected first quarter earnings Tuesday, and boosted its full-year profit guidance, as Botox sales continue to drive top-line growth for the Dublin-based pharmaceutical group.
Shares of the maker of Botox are struggling despite its latest results exceeding expectations.
Global stocks were mixed higher Tuesday, while U.S. equity futures drifted modestly into the red, as investors kept risk appetite in check ahead of a key series of trade talks between Washington and Beijing later this week that could define or collapse an elusive pact between the world's two largest economies.
U.S. stock futures slump as investors focus on trade talks later this week between Washington and Beijing; Lyft will issue its first earnings report as a public company on Tuesday; Anadarko says it favors Occidental's takeover bid over Chevron's offer.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.